Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04344821Not ApplicableCompleted

Curves 30/30 Study

Role: collaborator

NCT03138902Not ApplicableCompleted

Carbohydrate Intolerance Questionnaire Study

Role: collaborator

NCT03116711Not ApplicableCompleted

Effects of Diet Selection Based on Genetic Screening on Success to a Weight Loss Program

Role: collaborator

NCT03093792Not ApplicableCompleted

Effects of Diet Manipulation on Women in the Curves Program

Role: collaborator

NCT01271218Phase 4Completed

Effects of Glucosamine and Chondroitin Supplementation in Women With Knee Osteoarthritis Participating in an Exercise and Weight Loss Program

Role: collaborator

All 5 trials loaded